Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Scandinavian ChemoTech AB Series B leads the sector with a market cap of $8.71 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Scandinavian ChemoTech AB …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1051 |
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B |
$8.71 Million | Skr80.93 Million | Sweden | Skr3.40 | +5.92% | -7.36% | 219.87K |
| 1052 |
COSCIENS Biopharma Inc.
NASDAQ:CSCI |
$8.64 Million | $8.64 Million | USA | $7.65 | +0.53% | +4.79% | 25.29K |
| 1053 |
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN |
$8.60 Million | $8.60 Million | USA | $1.26 | -59.35% | -72.31% | 27.78 Million |
| 1054 |
Ascelia Pharma AB (publ)
ST:ACE |
$8.49 Million | Skr78.91 Million | Sweden | Skr0.62 | +0.48% | -3.72% | 23.68 Million |
| 1055 |
CNS Pharmaceuticals Inc
NASDAQ:CNSP |
$8.33 Million | $8.33 Million | USA | $5.70 | -2.40% | -5.16% | 201.66K |
| 1056 |
Pure Biologics Spólka Akcyjna
WAR:PUR |
$8.33 Million | zł30.25 Million | Poland | zł2.67 | -1.48% | -11.30% | 5.54 Million |
| 1057 |
Turnstone Biologics Corp. Common Stock
NASDAQ:TSBX |
$8.21 Million | $8.21 Million | USA | $0.36 | +0.00% | +0.00% | 0.00 |
| 1058 |
Traws Pharma Inc
NASDAQ:TRAW |
$8.13 Million | $8.13 Million | USA | $0.53 | +1.95% | -3.84% | 2.17 Million |
| 1059 |
Synaptogenix Inc
NASDAQ:SNPX |
$8.09 Million | $8.09 Million | USA | $5.82 | +0.00% | +0.00% | 424.16K |
| 1060 |
LISATA THERAP.INC.DL-001
F:8NE |
$8.06 Million | €6.90 Million | Germany | €1.18 | -2.48% | -11.28% | 0.00 |
| 1061 |
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX |
$7.99 Million | $7.99 Million | USA | $4.29 | -4.45% | -15.05% | 3.26 Million |
| 1062 |
Aprea Therapeutics Inc
NASDAQ:APRE |
$7.98 Million | $7.98 Million | USA | $0.75 | -4.17% | -5.69% | 11.54 Million |
| 1063 |
GRAFT POLYMER UK LS -001
F:J4I |
$7.90 Million | €6.76 Million | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1064 |
Senti Biosciences Inc
NASDAQ:SNTI |
$7.89 Million | $7.89 Million | USA | $0.30 | -0.70% | -9.91% | 5.03 Million |
| 1065 |
Collplant Biotechnologies Ltd
NASDAQ:CLGN |
$7.88 Million | $7.88 Million | USA | $3.40 | -2.58% | -4.23% | 201.48 Million |
| 1066 |
Imunon Inc
NASDAQ:IMNN |
$7.86 Million | $7.86 Million | USA | $1.40 | -4.44% | -11.39% | 2.39 Million |
| 1067 |
Bergenbio ASA
OL:BGBIO |
$7.75 Million | Nkr73.62 Million | Norway | Nkr0.47 | -5.91% | -61.29% | 13.59 Million |
| 1068 |
Bolt Biotherapeutics
NASDAQ:BOLT |
$7.74 Million | $7.74 Million | USA | $4.03 | +1.26% | +3.33% | 747.34K |
| 1069 |
Modus Therapeutics Holding AB
ST:MODTX |
$7.74 Million | Skr71.89 Million | Sweden | Skr0.41 | -0.24% | -6.41% | 41.80 Million |
| 1070 |
Spago Nanomedical AB
ST:SPAGO |
$7.51 Million | Skr69.80 Million | Sweden | Skr0.11 | -2.31% | -7.46% | 4.82 Million |
| 1071 |
Synlogic Inc
NASDAQ:SYBX |
$7.49 Million | $7.49 Million | USA | $1.17 | -4.10% | -4.10% | 555.65K |
| 1072 |
TME Pharma N.V.
PA:ALTME |
$7.34 Million | €6.28 Million | France | €0.10 | +1.42% | -16.64% | 126.54 Million |
| 1073 |
BioLight Life Sciences Ltd
TA:BOLT |
$7.27 Million | ILA2.71 Billion | Israel | ILA299.90 | -1.67% | -10.45% | 282.39K |
| 1074 |
Bioleaders Corporation
KQ:142760 |
$7.19 Million | ₩10.60 Billion | Korea | ₩503.00 | -8.55% | -14.75% | 27.69 Million |
| 1075 |
Akari Therapeutics PLC
NASDAQ:AKTX |
$7.15 Million | $7.15 Million | USA | $10.25 | -7.16% | -10.64% | 2.20 Million |
| 1076 |
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN |
$6.92 Million | $6.92 Million | USA | $3.51 | -0.28% | -5.39% | 580.08 Million |
| 1077 |
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA |
$6.80 Million | $6.80 Million | USA | $3.68 | -7.31% | -12.38% | 71.76 Million |
| 1078 |
Oxford BioMedica PLC
LSE:OXB |
$6.77 Million | GBX55.67 Billion | UK | GBX461.00 | +4.77% | +0.22% | 16.49 Million |
| 1079 |
Alzamend Neuro Inc
NASDAQ:ALZN |
$6.56 Million | $6.56 Million | USA | $1.75 | +1.74% | +2.94% | 2.41 Million |
| 1080 |
Curative Biotechnology Inc
NYSE MKT:CUBT |
$6.51 Million | $6.51 Million | USA | $0.85 | -15.00% | -8.60% | 18.23K |
| 1081 |
OSR Holdings Inc
NASDAQ:OSRH |
$6.50 Million | $6.50 Million | USA | $0.19 | -7.86% | -24.41% | 589.78 Million |
| 1082 |
Immuron Ltd ADR
NASDAQ:IMRN |
$6.45 Million | $6.45 Million | USA | $0.88 | +0.40% | +6.82% | 689.90K |
| 1083 |
Processa Pharmaceuticals Inc
NASDAQ:PCSA |
$6.30 Million | $6.30 Million | USA | $1.88 | -9.62% | -10.48% | 945.74K |
| 1084 |
Marvel Biosciences Corp
V:MRVL |
$6.29 Million | CA$8.70 Million | Canada | CA$0.15 | +0.00% | +0.00% | 2.48 Million |
| 1085 |
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF |
$6.23 Million | $6.23 Million | USA | $2.91 | -1.69% | -8.20% | 734.49K |
| 1086 |
Titan Pharmaceuticals Inc
NASDAQ:TTNP |
$6.13 Million | $6.13 Million | USA | $4.61 | +0.00% | +7.63% | 2.51 Million |
| 1087 |
INVEX Therapeutics Ltd
AU:IXC |
$6.12 Million | AU$8.64 Million | Australia | AU$0.12 | +0.00% | +0.00% | 862.58K |
| 1088 |
AcouSort AB
ST:ACOU |
$6.06 Million | Skr56.30 Million | Sweden | Skr2.66 | -1.12% | -8.28% | 646.76K |
| 1089 |
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH |
$6.04 Million | $6.04 Million | USA | $0.48 | -10.26% | -11.11% | 520.01K |
| 1090 |
Lexaria Bioscience Corp
NASDAQ:LEXX |
$5.87 Million | $5.87 Million | USA | $3.55 | -10.58% | -73.12% | 2.29 Million |
| 1091 |
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO |
$5.86 Million | $5.86 Million | USA | $2.00 | -3.38% | +7.53% | 1.18 Million |
| 1092 |
Creative Medical Technology Holdings Inc
NASDAQ:CELZ |
$5.83 Million | $5.83 Million | USA | $0.89 | +0.81% | -20.27% | 17.81 Million |
| 1093 |
Acurx Pharmaceuticals LLC
NASDAQ:ACXP |
$5.82 Million | $5.82 Million | USA | $1.36 | -2.52% | -4.58% | 4.25 Million |
| 1094 |
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND |
$5.61 Million | $5.61 Million | USA | $0.86 | -8.44% | -25.49% | 22.04 Million |
| 1095 |
BRITANNIA LIFE SCIENCES
F:L020 |
$5.50 Million | €4.71 Million | Germany | €0.03 | +1.75% | +0.00% | 0.00 |
| 1096 |
NuCana PLC
NASDAQ:NCNA |
$5.49 Million | $5.49 Million | USA | $1.32 | +0.00% | -5.04% | 1.83 Million |
| 1097 |
COLLPLANT BIOTECH. IS-01
F:CPT |
$5.48 Million | €4.69 Million | Germany | €3.08 | +4.76% | -12.00% | 4.73K |
| 1098 |
BetterLife Pharma Inc
F:NPAU |
$5.42 Million | €4.64 Million | Germany | €0.07 | +104.55% | +117.74% | 1.02K |
| 1099 |
Adalta Ltd
AU:1AD |
$5.41 Million | AU$7.65 Million | Australia | AU$0.00 | +0.00% | +0.00% | 19.96 Million |
| 1100 |
Pulmatrix Inc
NASDAQ:PULM |
$5.28 Million | $5.28 Million | USA | $1.45 | -0.34% | +3.96% | 615.61K |
| 1101 |
Exact Therapeutics AS
OL:EXTX |
$5.26 Million | Nkr49.98 Million | Norway | Nkr0.79 | +1.28% | +8.97% | 886.70K |
| 1102 |
Combigene AB
ST:COMBI |
$5.24 Million | Skr48.71 Million | Sweden | Skr2.46 | +0.00% | +0.00% | 14.23K |
| 1103 |
Quantum Genomics SA
PA:ALQGC |
$5.03 Million | €4.30 Million | France | €0.07 | +0.00% | +0.00% | 0.00 |
| 1104 |
Xenetic Biosciences Inc
NASDAQ:XBIO |
$4.98 Million | $4.98 Million | USA | $4.27 | -1.39% | -8.57% | 858.94K |
| 1105 |
Plant Advanced Technologies SA
PA:ALPAT |
$4.92 Million | €4.21 Million | France | €4.28 | +0.00% | -0.93% | 9.82K |
| 1106 |
Bio Green Med Solution, Inc.
NASDAQ:BGMS |
$4.86 Million | $4.86 Million | USA | $1.05 | +17.30% | +16.99% | 3.50 Million |
| 1107 |
Fluicell AB
ST:FLUI |
$4.85 Million | Skr45.06 Million | Sweden | Skr32.80 | -1.80% | +7.89% | 208.99K |
| 1108 |
Purple Biotech Ltd
TA:PPBT |
$4.84 Million | ILA1.81 Billion | Israel | ILA1.00 | +0.00% | +0.00% | 582.00K |
| 1109 |
Oncozenge AB
ST:ONCOZ |
$4.83 Million | Skr44.88 Million | Sweden | Skr3.20 | -0.93% | -8.71% | 1.53 Million |
| 1110 |
Moolec Science SA Ordinary Shares
NASDAQ:MLEC |
$4.81 Million | $4.81 Million | USA | $6.63 | -6.68% | -4.39% | 555.36K |
| 1111 |
Salarius Pharmaceuticals Inc
NASDAQ:SLRX |
$4.81 Million | $4.81 Million | USA | $0.82 | -2.40% | +26.59% | 14.81 Million |
| 1112 |
Qualigen Therapeutics Inc
NASDAQ:QLGN |
$4.74 Million | $4.74 Million | USA | $2.33 | +0.30% | -8.98% | 2.43 Million |
| 1113 |
Eterna Therapeutics Inc
NASDAQ:ERNA |
$4.69 Million | $4.69 Million | USA | $4.08 | -4.45% | -5.34% | 1.22 Million |
| 1114 |
ONCODES.PREC.MED. EO-34
F:ZR8 |
$4.55 Million | €3.89 Million | Germany | €0.20 | +0.00% | -10.53% | 0.00 |
| 1115 |
Dermata Therapeutics Inc
NASDAQ:DRMA |
$4.55 Million | $4.55 Million | USA | $1.13 | -1.74% | -6.61% | 20.22 Million |
| 1116 |
Vectus Biosystems Ltd
AU:VBS |
$4.54 Million | AU$6.41 Million | Australia | AU$0.12 | +0.00% | -27.27% | 287.06K |
| 1117 |
Aptose Biosciences Inc
TO:APS |
$4.43 Million | CA$6.13 Million | Canada | CA$2.40 | +0.00% | +9.09% | 85.56K |
| 1118 |
DMD Digital Health Connections Group Inc
NASDAQ:APTOF |
$4.31 Million | $4.31 Million | USA | $1.69 | +0.00% | +9.03% | 52.70K |
| 1119 |
CASI Pharmaceuticals Inc
NASDAQ:CASI |
$4.26 Million | $4.26 Million | USA | $0.24 | +17.06% | -68.82% | 11.66 Million |
| 1120 |
Avacta Group PLC
LSE:AVCT |
$4.26 Million | GBX35.01 Billion | UK | GBX80.00 | +5.96% | +20.30% | 29.82 Million |
| 1121 |
XTL Biopharmaceuticals Ltd
TA:XTLB |
$4.25 Million | ILA1.59 Billion | Israel | ILA1.80 | +0.00% | -5.26% | 30.55 Million |
| 1122 |
International Biotechnology Trust plc
LSE:IBT |
$4.21 Million | GBX34.61 Billion | UK | GBX1085.00 | -3.13% | -2.25% | 1.83 Million |
| 1123 |
Zelira Therapeutics Ltd
AU:ZLD |
$4.21 Million | AU$5.95 Million | Australia | AU$0.50 | +0.00% | +0.00% | 0.00 |
| 1124 |
Biophytis S.A.
NASDAQ:BPTSY |
$4.19 Million | $4.19 Million | USA | $2.08 | +0.00% | +0.00% | 0.00 |
| 1125 |
Inhalerx Ltd
AU:IRX |
$4.18 Million | AU$5.91 Million | Australia | AU$0.02 | +4.35% | +33.33% | 1.37 Million |
| 1126 |
Addex Therapeutics Ltd
NASDAQ:ADXN |
$4.13 Million | $4.13 Million | USA | $3.26 | -6.32% | -10.68% | 8.49 Million |
| 1127 |
Kineta, Inc.
NASDAQ:KANT |
$4.12 Million | $4.12 Million | USA | $0.34 | +0.00% | +0.00% | 0.00 |
| 1128 |
PharmaCyte Biotech Inc
NASDAQ:PMCB |
$4.10 Million | $4.10 Million | USA | $0.38 | -2.47% | -21.42% | 3.64 Million |
| 1129 |
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD |
$4.10 Million | $4.10 Million | USA | $3.84 | -6.11% | -6.77% | 2.50 Million |
| 1130 |
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB |
$4.09 Million | $4.09 Million | USA | $0.70 | +5.09% | +23.06% | 7.31 Million |
| 1131 |
Moleculin Biotech Inc
NASDAQ:MBRX |
$4.01 Million | $4.01 Million | USA | $0.75 | -3.04% | +5.86% | 18.26 Million |
| 1132 |
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS |
$3.97 Million | $3.97 Million | USA | $3.01 | -11.73% | -8.23% | 54.77 Million |
| 1133 |
NLS Pharmaceutics AG
NASDAQ:NLSP |
$3.97 Million | $3.97 Million | USA | $0.76 | +2.97% | -52.08% | 43.52 Million |
| 1134 |
Kane Biotech Inc
V:KNE |
$3.95 Million | CA$5.46 Million | Canada | CA$0.03 | +0.00% | +0.00% | 4.47 Million |
| 1135 |
Biotron Ltd
AU:BIT |
$3.94 Million | AU$5.57 Million | Australia | AU$0.00 | +0.00% | +0.00% | 37.93 Million |
| 1136 |
Can Fite Biopharma Ltd
TA:CANF |
$3.93 Million | ILA1.47 Billion | Israel | ILA342.20 | -1.69% | -9.09% | 675.14K |
| 1137 |
Addex Therapeutics Ltd
SW:ADXN |
$3.89 Million | CHF3.08 Million | Switzerland | CHF0.02 | -0.82% | -10.37% | 37.64 Million |
| 1138 |
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ:LABT |
$3.80 Million | $3.80 Million | USA | $2.17 | +2.36% | +15.43% | 23.45 Million |
| 1139 |
Alaunos Therapeutics Inc
NASDAQ:TCRT |
$3.79 Million | $3.79 Million | USA | $1.49 | -1.32% | -10.78% | 302.57K |
| 1140 |
HCW Biologics Inc
NASDAQ:HCWB |
$3.76 Million | $3.76 Million | USA | $2.05 | -6.82% | -30.27% | 7.24 Million |
| 1141 |
BIOVAXYS TECHNOLOGY CORP.
F:5LB |
$3.75 Million | €3.20 Million | Germany | €0.15 | +0.00% | +0.00% | 0.00 |
| 1142 |
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB |
$3.74 Million | $3.74 Million | USA | $4.82 | +4.33% | -7.49% | 4.94 Million |
| 1143 |
Rakovina Therapeutics Inc
V:RKV |
$3.70 Million | CA$5.12 Million | Canada | CA$0.27 | +6.00% | +20.45% | 785.99K |
| 1144 |
Bio-Gene Technology Ltd
AU:BGT |
$3.67 Million | AU$5.19 Million | Australia | AU$0.02 | +0.00% | +0.00% | 5.74 Million |
| 1145 |
Evogene
TA:EVGN |
$3.66 Million | ILA1.36 Billion | Israel | ILA156.50 | +5.74% | -8.26% | 1.62 Million |
| 1146 |
GLOW LIFETECH CORP.
F:9DO |
$3.66 Million | €3.13 Million | Germany | €0.02 | +10.53% | +27.27% | 12.00K |
| 1147 |
VivoSim Labs, Inc.
NASDAQ:VIVS |
$3.65 Million | $3.65 Million | USA | $0.27 | -3.06% | -2.68% | 18.80 Million |
| 1148 |
Soligenix Inc.
NASDAQ:SNGX |
$3.63 Million | $3.63 Million | USA | $0.36 | -0.19% | -5.24% | 5.16 Million |
| 1149 |
Revelation Biosciences Inc
NASDAQ:REVB |
$3.63 Million | $3.63 Million | USA | $0.91 | -4.69% | -9.86% | 839.14K |
| 1150 |
XORTX Therapeutics Inc
V:XRTX |
$3.55 Million | CA$4.91 Million | Canada | CA$3.19 | +4.59% | +13.93% | 24.13K |
| 1151 |
Tissue Repair Ltd
AU:TRP |
$3.51 Million | AU$4.96 Million | Australia | AU$0.08 | -8.89% | +2.50% | 1.71 Million |
| 1152 |
Silo Pharma Inc
NASDAQ:SILO |
$3.40 Million | $3.40 Million | USA | $1.94 | -6.28% | -19.17% | 1.39 Million |
| 1153 |
Mustang Bio Inc
NASDAQ:MBIO |
$3.39 Million | $3.39 Million | USA | $0.50 | -1.29% | -7.27% | 530.31K |
| 1154 |
GRI Bio Inc.
NASDAQ:GRI |
$3.35 Million | $3.35 Million | USA | $1.89 | -0.53% | -5.50% | 17.18 Million |
| 1155 |
PreveCeutical Medical Inc
F:18H |
$3.34 Million | €2.85 Million | Germany | €0.01 | -54.55% | -77.27% | 356.50K |
| 1156 |
BIOMIND LABS INC.
F:3XI |
$3.31 Million | €2.83 Million | Germany | €0.04 | +0.00% | -30.48% | 10.50K |
| 1157 |
Azitra Inc
NYSE MKT:AZTR |
$3.30 Million | $3.30 Million | USA | $0.20 | -3.77% | +10.57% | 13.26 Million |
| 1158 |
Niki BioSolutions, Inc.
NASDAQ:NIKI |
$3.22 Million | $3.22 Million | USA | $5.07 | -13.18% | -18.23% | 5.28 Million |
| 1159 |
Iterum Therapeutics PLC
NASDAQ:ITRM |
$3.20 Million | $3.20 Million | USA | $0.06 | -12.01% | +9.27% | 3.77 Million |
| 1160 |
Guard Therapeutics International AB
ST:GUARD |
$3.19 Million | Skr29.61 Million | Sweden | Skr1.47 | +1.24% | +10.54% | 446.11K |
| 1161 |
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ:SXTP |
$3.16 Million | $3.16 Million | USA | $0.90 | -0.11% | -5.37% | 1.46 Million |
| 1162 |
Psyence Biomedical Ltd. Common Shares
NASDAQ:PBM |
$3.16 Million | $3.16 Million | USA | $6.07 | +1.17% | +33.70% | 2.18 Million |
| 1163 |
Innovotech Inc
V:IOT |
$3.15 Million | CA$4.36 Million | Canada | CA$0.08 | +6.67% | +0.00% | 673.37K |
| 1164 |
ValiRx plc
LSE:VAL |
$3.05 Million | £2.27 Million | UK | £0.15 | +0.00% | +3.57% | 96.06 Million |
| 1165 |
Opthea Limited
NASDAQ:OPTEY |
$2.94 Million | $2.94 Million | USA | $0.02 | +0.00% | -22.17% | 358.37K |
| 1166 |
Green Cross Holdings Preference Shares
KO:005257 |
$2.92 Million | ₩4.31 Billion | Korea | ₩17890.00 | +2.23% | +1.07% | 11.59K |
| 1167 |
ACRUX Ltd
AU:ACR |
$2.91 Million | AU$4.11 Million | Australia | AU$0.01 | -9.09% | -9.09% | 22.04 Million |
| 1168 |
LOBE SCIENCES LTD
F:6YX0 |
$2.90 Million | €2.48 Million | Germany | €0.03 | +0.00% | +0.00% | 0.00 |
| 1169 |
Purple Biotech
NASDAQ:PPBT |
$2.80 Million | $2.80 Million | USA | $1.72 | -2.27% | -1.71% | 78.70 Million |
| 1170 |
Conduit Pharmaceuticals Inc.
NASDAQ:CDT |
$2.78 Million | $2.78 Million | USA | $0.20 | -7.31% | -67.52% | 72.77 Million |
| 1171 |
LakeShore Biopharma Co., Ltd
NYSE:LSBCF |
$2.76 Million | $2.76 Million | USA | $0.07 | +0.00% | +0.00% | 55.20K |
| 1172 |
Unity Biotechnology Inc
NASDAQ:UBX |
$2.75 Million | $2.75 Million | USA | $0.16 | +0.00% | +0.00% | 1.42 Million |
| 1173 |
Curis Inc
NASDAQ:CRIS |
$2.74 Million | $2.74 Million | USA | $1.13 | +0.89% | -16.30% | 7.02 Million |
| 1174 |
Genprex Inc
NASDAQ:GNPX |
$2.71 Million | $2.71 Million | USA | $3.31 | -4.06% | -5.43% | 5.94 Million |
| 1175 |
Omega Therapeutics Inc
NASDAQ:OMGA |
$2.69 Million | $2.69 Million | USA | $0.05 | +0.00% | +0.00% | 105.64K |
| 1176 |
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI |
$2.68 Million | $2.68 Million | USA | $0.18 | -8.29% | -7.32% | 212.03 Million |
| 1177 |
Artelo Biosciences Inc
NASDAQ:ARTL |
$2.51 Million | $2.51 Million | USA | $5.34 | +9.65% | -11.59% | 12.96 Million |
| 1178 |
Palatin Technologies Inc
NYSE MKT:PTN |
$2.45 Million | $2.45 Million | USA | $23.00 | +4.59% | +0.00% | 243.66K |
| 1179 |
Quest PharmaTech Inc
V:QPT |
$2.45 Million | CA$3.38 Million | Canada | CA$0.02 | +0.00% | +0.00% | 2.22 Million |
| 1180 |
Bioatla Inc
NASDAQ:BCAB |
$2.44 Million | $2.44 Million | USA | $1.47 | -2.00% | +13.08% | 2.74 Million |
| 1181 |
Oragenics Inc
NYSE MKT:OGEN |
$2.42 Million | $2.42 Million | USA | $0.60 | +1.69% | +5.13% | 1.11 Million |
| 1182 |
Biophytis S.A.
PA:ALBPS |
$2.38 Million | €2.03 Million | France | €0.05 | +1.60% | -27.43% | 1.41 Billion |
| 1183 |
Cyclerion Therapeutics Inc
NASDAQ:CYCN |
$2.25 Million | $2.25 Million | USA | $23.94 | +463.29% | +500.00% | 1.48 Million |
| 1184 |
Alligator Bioscience AB
ST:ATORX |
$2.23 Million | Skr20.71 Million | Sweden | Skr0.02 | +4.19% | -13.85% | 455.66 Million |
| 1185 |
Clearside Biomedical Inc
NASDAQ:CLSD |
$2.15 Million | $2.15 Million | USA | $0.41 | -26.96% | -85.66% | 12.52 Million |
| 1186 |
Aptevo Therapeutics Inc
NASDAQ:APVO |
$2.13 Million | $2.13 Million | USA | $1.71 | -5.00% | -1.72% | 4.26 Million |
| 1187 |
Abpro Holdings, Inc.
NYSE:ABP |
$2.00 Million | $2.00 Million | USA | $6.15 | -0.81% | +0.82% | 230.50K |
| 1188 |
Aditxt Inc.
NASDAQ:ADTX |
$2.00 Million | $2.00 Million | USA | $0.01 | -12.82% | -5.56% | 674.47 Million |
| 1189 |
Kancera AB (publ)
ST:KAN |
$1.98 Million | Skr18.44 Million | Sweden | Skr0.15 | -23.82% | -37.24% | 29.17 Million |
| 1190 |
PALATIN TECHS DL-01
F:PTN |
$1.97 Million | €1.68 Million | Germany | €3.30 | +0.00% | +0.00% | 0.00 |
| 1191 |
Medigene AG
XETRA:MDG1 |
$1.97 Million | €1.68 Million | Germany | €0.13 | +0.00% | +0.00% | 189.47K |
| 1192 |
Plantarc Bio Ltd
TA:PLNT |
$1.96 Million | ILA731.02 Million | Israel | ILA220.90 | +0.00% | +1.33% | 217.47K |
| 1193 |
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN |
$1.94 Million | $1.94 Million | USA | $0.39 | +7.84% | +9.69% | 132.56 Million |
| 1194 |
Propanc Biopharma, Inc. Common Stock
NASDAQ:PPCB |
$1.94 Million | $1.94 Million | USA | $0.85 | -7.71% | -17.48% | 103.95 Million |
| 1195 |
Prostemics Co. Ltd
KQ:203690 |
$1.88 Million | ₩2.78 Billion | Korea | ₩139.00 | +0.00% | +0.00% | 3.45 Million |
| 1196 |
Valion Bio Inc
NASDAQ:VBIO |
$1.87 Million | $1.87 Million | USA | $2.11 | +0.48% | -23.83% | 521.45 Million |
| 1197 |
Cynata Therapeutics Ltd
AU:CYP |
$1.85 Million | AU$2.61 Million | Australia | AU$0.01 | +0.00% | +10.00% | 9.70 Million |
| 1198 |
Medesis Pharma SA
PA:ALMDP |
$1.80 Million | €1.54 Million | France | €0.35 | +0.00% | +0.00% | 0.00 |
| 1199 |
Decoy Therapeutics Inc.
NASDAQ:DCOY |
$1.78 Million | $1.78 Million | USA | $2.71 | +0.00% | +0.74% | 644.75K |
| 1200 |
Transcode Therapeutics Inc
NASDAQ:RNAZ |
$1.69 Million | $1.69 Million | USA | $1.60 | -3.03% | -22.33% | 1.85 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries